Olivier Lozach

4.7k citations

87 papers · 3.8k indexed · h-index 37

Organic Chemistry top 0.5%
Molecular Biology top 5%
Pharmacology top 2%
Oncology top 10%
Toxicology top 0.5%

Co-authors: Laurent Meijer Yoan Ferandin Nirupma Singh Sham M. Sondhi Ashok Kumar Thierry Besson Sylvain Routier Karima Bettayeb
Topics: Synthesis and Biological Evaluation (20 papers)Cancer therapeutics and mechanisms (19 papers)Synthesis and Reactivity of Heterocycles (18 papers)
Cited by: Organic Chemistry Toxicology Pharmacology
Journals: Cancer Research International Journal of Molecular Sciences Journal of Medicinal Chemistry
Partner nations: France Germany Greece

In The Last Decade

Olivier Lozach

87 papers receiving 3.7k citations

Peers

Countries citing papers authored by Olivier Lozach

Since Specialization

Citations

This map shows the geographic impact of Olivier Lozach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Lozach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Lozach more than expected).

Fields of papers citing papers by Olivier Lozach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Lozach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Lozach. The network helps show where Olivier Lozach may publish in the future.

Co-authorship network of co-authors of Olivier Lozach

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Lozach. A scholar is included among the top collaborators of Olivier Lozach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Lozach. Olivier Lozach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis, biological evaluation and molecular modeling studies of imidazo[1,2- a ]pyridines derivatives as protein kinase inhibitors 2016 ·European Journal of Medicinal Chemistry ·(unknown),Jordi Rodrigo,Blandine Baratte,Thomas Robert,(unknown),Olivier Lozach,(unknown),Stéphane Bach,Jean‐Daniel Brion,Mouâd Alami,Abdallah Hamzé	26
2	Synthesis and biological evaluation of tetrahydro[1,4]diazepino[1,2-a]indol-1-ones as cyclin-dependent kinase inhibitors. 2014 ·HAL (Le Centre pour la Communication Scientifique Directe) ·(unknown),Guy Fournet,Olivier Lozach,Lionel Perrin,Laurent Meijer,Benoı̂t Joseph	11
3	Synthesis and optimization of an original V-shaped collection of 4-7-disubstituted Pyrido[3,2-d]pyrimidines as CDK5 and DYRK1A inhibitors 2014 ·European Journal of Medicinal Chemistry ·(unknown),Abdellatif Tikad,Stéphane Bourg,Pascal Bonnet,Olivier Lozach,Laurent Meijer,(unknown),(unknown),Gérald Guillaumet,Sylvain Routier	35
4	Potent inhibitors of CDK5 derived from roscovitine: Synthesis, biological evaluation and molecular modelling 2012 ·Bioorganic & Medicinal Chemistry Letters ·Luc Demange,(unknown),Olivier Lozach,Yoan Ferandin,Nohad Gresh,Laurent Meijer,Hervé Galons	33
5	Synthesis and biological evaluation of new 5-benzylated 4-oxo-3,4-dihydro-5H-pyridazino[4,5-b]indoles as PI3Kα inhibitors 2012 ·European Journal of Medicinal Chemistry ·(unknown),Cédric Logé,(unknown),(unknown),Rémy Le Guével,Christiane Guillouzo,Jean‐François Lohier,Jana Sopková‐de Oliveira Santos,Olivier Lozach,Laurent Meijer,(unknown),Hélène Bénédetti,Jean‐Michel Robert	30
6	Synthesis and biological evaluation of analogs of the marine alkaloids granulatimide and isogranulatimide 2012 ·European Journal of Medicinal Chemistry ·(unknown),Delphine Lamoral‐Theys,Céline Frongia,Stefan Chassaing,Céline Bruyère,Olivier Lozach,Laurent Meijer,Bernard Ducommun,Róbert Kiss,Evelyne Delfourne	25
7	Synthesis of chromeno[3,4-b]indoles as Lamellarin D analogues : A novel DYRK1A inhibitor class 2012 ·European Journal of Medicinal Chemistry ·(unknown),Emeline Vedrenne,Frédéric Buron,Jean‐Yves Mérour,(unknown),Stéphane Bourg,Olivier Lozach,Laurent Meijer,Brigitte Baldeyrou,Amélie Lansiaux,Sylvain Routier	80
8	Synthesis and biological evaluation of N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amines and their pyrido and pyrazino analogues as Ser/Thr kinase inhibitors 2012 ·European Journal of Medicinal Chemistry ·(unknown),Pascal Marchand,(unknown),Marie‐Renée Nourrisson,Muriel Duflos,Olivier Lozach,Nadège Loaëc,Laurent Meijer,Thierry Besson	50
9	Synthesis and biological evaluation of new 3-(6-hydroxyindol-2-yl)-5-(Phenyl) pyridine or pyrazine V-Shaped molecules as kinase inhibitors and cytotoxic agents 2011 ·European Journal of Medicinal Chemistry ·(unknown),Joanna Brzeszcz,Valérie Bénéteau,Olivier Lozach,Laurent Meijer,(unknown),Christiane Guillouzo,K. Lewiński,Stéphane Bourg,Lionel Colliandre,Sylvain Routier,Jean‐Yves Mérour	39
10	Synthesis and biological evaluation of new penta- and heptacyclic indolo- and quinolinocarbazole ring systems obtained via Pd0 catalysed reductive N-heteroannulation 2010 ·Organic & Biomolecular Chemistry ·(unknown),(unknown),(unknown),Amélie Lansiaux,(unknown),(unknown),(unknown),Jean‐Marc Nuzillard,(unknown),(unknown),Olivier Lozach,Laurent Meijer,Jean‐François Riou,(unknown),János Sápi	14
11	Synthesis and preliminary biological evaluation of new derivatives of the marine alkaloid leucettamine B as kinase inhibitors 2009 ·European Journal of Medicinal Chemistry ·(unknown),Stéven Renault,Olivier Lozach,Laurent Meijer,Ludovic Paquin,François Carreaux,Jean Pierre Bazureau	33
12	Rebeccamycin Derivatives as Dual DNA-Damaging Agents and Potent Checkpoint Kinase 1 Inhibitors 2008 ·Molecular Pharmacology ·Christelle Marminon,Fabrice Anizon,Pascale Moreau,Bruno Pfeiffer,Alain St. Pierre,Roy M. Golsteyn,Paul Peixoto,Marie‐Paule Hildebrand,Marie‐Hélène David‐Cordonnier,Olivier Lozach,Laurent Meijer,Michelle Prudhomme	16
13	Synthesis of 3,5-bis(2-indolyl)pyridine and 3-[(2-indolyl)-5-phenyl]pyridine derivatives as CDK inhibitors and cytotoxic agents 2008 ·Bioorganic & Medicinal Chemistry ·Ulrich Jacquemard,Nathalie Dias,Amélie Lansiaux,Christian Bailly,Cédric Logé,Jean‐Michel Robert,Olivier Lozach,Laurent Meijer,Jean‐Yves Mérour,Sylvain Routier	53
14	Meriolins, a New Class of Cell Death–Inducing Kinase Inhibitors with Enhanced Selectivity for Cyclin-Dependent Kinases 2007 ·Cancer Research ·Karima Bettayeb,Òscar M. Tirado,Séverine Marionneau‐Lambot,Yoan Ferandin,Olivier Lozach,Jonathan C. Morris,Silvia Mateo‐Lozano,Peter Drueckes,Christoph Schächtele,Michael H.G. Kubbutat,François Mouton‐Liger,Bernard Marquet,Benoı̂t Joseph,Aude Echalier,Jane Endicott,Vicente Notario,Laurent Meijer	95
15	Thiazolo[5,4-f]quinazolin-9-ones, inhibitors of glycogen synthase kinase-3 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Cédric Logé,(unknown),Jean‐Michel Robert,Olivier Lozach,(unknown),Laurent Meijer,Valérie Thiéry,Thierry Besson	52
16	Antimalarial potential of xestoquinone, a protein kinase inhibitor isolated from a Vanuatu marine sponge Xestospongia sp. 2006 ·Bioorganic & Medicinal Chemistry ·Dominique Laurent,Valérie Jullian,A.D.C. Parenty,Martine Knibiehler,Dominique Dorin,Sophie Schmitt,Olivier Lozach,(unknown),(unknown),(unknown),Séverine Maurel,Christian Doerig,Laurent Meijer,Michel Sauvain	60
17	Synthesis, anti-inflammatory, analgesic and kinase (CDK-1, CDK-5 and GSK-3) inhibition activity evaluation of benzimidazole/benzoxazole derivatives and some Schiff’s bases 2006 ·Bioorganic & Medicinal Chemistry ·Sham M. Sondhi,Nirupma Singh,Ashok Kumar,Olivier Lozach,Laurent Meijer	296
18	A Pd(0) based cross-coupling approach to the synthesis of 2-amidopurines and their evaluation as CDK inhibitors 2006 ·Bioorganic & Medicinal Chemistry ·(unknown),Michel Legraverend,(unknown),Olivier Lozach,Laurent Meijer,David S. Grierson	17
19	Novel CDK inhibition profiles of structurally varied 1-aza-9-oxafluorenes 2004 ·Bioorganic & Medicinal Chemistry Letters ·B. VOIGT,Laurent Meijer,Olivier Lozach,Christoph Schächtele,Frank Totzke,Andreas Hilgeroth	39
20	Synthesis and Target Identification of Hymenialdisine Analogs 2004 ·Chemistry & Biology ·Yongqin Wan,Wooyoung Hur,Charles Y. Cho,Yi Liu,(unknown),Olivier Lozach,Stéphane Bach,Thomas U. Mayer,(unknown),Laurent Meijer,Nathanael S. Gray	117

About Olivier Lozach

Olivier Lozach is a scholar working on Toxicology, Organic Chemistry and Molecular Biology, having authored 87 papers that have together received 3.8k indexed citations. Recurring topics across this work include Synthesis and Biological Evaluation (20 papers), Cancer therapeutics and mechanisms (19 papers) and Synthesis and Reactivity of Heterocycles (18 papers). The work is most often cited by research in Organic Chemistry (2.4k citations), Toxicology (239 citations) and Pharmacology (400 citations). Olivier Lozach has collaborated with scholars based in France, Germany and Greece. Frequent co-authors include Laurent Meijer, Yoan Ferandin, Nirupma Singh, Sham M. Sondhi, Ashok Kumar, Thierry Besson, Sylvain Routier, Karima Bettayeb, Valérie Thiéry and Jean‐Yves Mérour. Their work appears in journals such as Cancer Research, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact